Corporate Debt security Details
Nuvo Pharmaceuticals (Ireland) Designated Activity Company
| Description | $30,000,000 Amortization Loan Note 1 due 31 December 2024 |
|---|---|
| Series | Loan Note 1 |
| Coupon | Fixed 3.5 |
| Coupon Frequency | Annual |
| Maturity Date | 31 Dec 2024 |
| Issue Date | 31 Dec 2018 |
| Currency | USD |
| Listed Amount Outstanding | 30,000,000.00 |
| Minimum Denomination | 30,000,000.00 |
| 1st Interest Payment Date | 01 Apr 2019 |
| Listing Type | Primary Listing on CSX |
| ISIN | IE00BJQZJN76 |
| Auditor | Ernst & Young  |
| Legal Advisor | Byrne Wallace |
| Paying Agent | Cortland Securities LLC |
| Registrar | Cortland Securities LLC |
Related Announcements
| Release Date | Title |
|---|---|
| 16 Nov 2020 | NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY: COMPANY ANNOUNCEMENT: Q3 FINANCIALS  |